"money (which has been a constant topic over on th
Post# of 148158
Read More: https://investorshangout.com/post/view?id=609...9lts"
At the risk of coming across as too much of a realist, you do understand that we owe over $20 million to Samsung Biologics and must continue to make payments on the last finance deal where we also borrowed $28.5 million? Since there is no revenue, we are using this newly borrowed money to pay the debt on the old money we borrowed.
I'm no accountant, but I'd say that it's premature to say that money is not an issue at all.